These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37370848)

  • 1. Identification, and Experimental and Bioinformatics Validation of an Immune-Related Prognosis Gene Signature for Low-Grade Glioma Based on mRNAsi.
    Wang Y; Ye S; Wu D; Xu Z; Wei W; Duan F; Luo M
    Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses.
    Ye S; Yang B; Zhang T; Wei W; Li Z; Chen J; Li X
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Guo F; Hong J
    Front Genet; 2020; 11():441. PubMed ID: 32431729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a novel stemness-related prognostic model for neuroblastoma using integrated machine learning and bioinformatics analyses.
    Xia Y; Wang C; Li X; Gao M; Hogg HDJ; Tunthanathip T; Hulsen T; Tian X; Zhao Q
    Transl Pediatr; 2024 Jan; 13(1):91-109. PubMed ID: 38323183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma.
    Deng X; Lin D; Chen B; Zhang X; Xu X; Yang Z; Shen X; Yang L; Lu X; Sheng H; Yin B; Zhang N; Lin J
    Front Oncol; 2019; 9():1310. PubMed ID: 31824866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 7. Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma.
    Cao Y; Zhu H; Chen Q; Huang H; Xie D; Li X; Jiang X; Ren C; Peng J
    Front Pharmacol; 2022; 13():914667. PubMed ID: 36091778
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.
    Tan S; Spear R; Zhao J; Sun X; Wang P
    Front Genet; 2022; 13():905047. PubMed ID: 35832194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma.
    Tang G; Peng J; Huo L; Yin W
    BMC Bioinformatics; 2023 Jun; 24(1):225. PubMed ID: 37264314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma.
    Xiao K; Liu Q; Peng G; Su J; Qin CY; Wang XY
    PeerJ; 2020; 8():e8312. PubMed ID: 31921517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
    Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
    Front Immunol; 2020; 11():603341. PubMed ID: 33363544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
    Zhang M; Wang X; Chen X; Zhang Q; Hong J
    Front Genet; 2020; 11():363. PubMed ID: 32351547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma.
    Wang J; Ren J; Liu J; Zhang L; Yuan Q; Dong B
    Bosn J Basic Med Sci; 2022 Sep; 22(5):728-750. PubMed ID: 35276059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas.
    Ye L; Xu Y; Hu P; Wang L; Yang J; Yuan F; Wang Y; Zhang C; Tian D; Chen Q
    Front Mol Neurosci; 2021; 14():720899. PubMed ID: 34776862
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic value of γ-aminobutyric acidergic synapse-associated signature for lower-grade gliomas.
    Jiang H; Sun Z; Li F; Chen Q
    Front Immunol; 2022; 13():983569. PubMed ID: 36405708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of four immune-related genes in lower-grade gliomas: a biomarker discovery study.
    Wang S; Wang Z; Liu Z; Wu J
    Front Genet; 2024; 15():1403587. PubMed ID: 39192888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.
    Lei K; Li J; Tu Z; Liu F; Ye M; Wu M; Zhu Y; Luo M; Lin L; Tao C; Huang K; Zhu X
    Front Oncol; 2021; 11():665870. PubMed ID: 34123829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma.
    Huang QR; Li JW; Yan P; Jiang Q; Guo FZ; Zhao YN; Mo LG
    Front Neurol; 2022; 13():861438. PubMed ID: 35832170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prognostic Microenvironment-Related Immune Signature
    Qiu H; Li Y; Cheng S; Li J; He C; Li J
    Front Oncol; 2020; 10():580263. PubMed ID: 33425732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structuring and validating a prognostic model for low-grade gliomas based on the genes for plasma membrane tension.
    Li J; Lv F; Jin T
    Front Neurol; 2022; 13():1024869. PubMed ID: 36408514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.